Latamoxef is a third-generation oxacephem antibiotic structurally related to cephalosporins, used for the treatment of serious bacterial infections such as pneumonia, urinary tract infections, and skin… Read more
Latamoxef is a third-generation oxacephem antibiotic structurally related to cephalosporins, used for the treatment of serious bacterial infections such as pneumonia, urinary tract infections, and skin infections. By inhibiting bacterial cell wall synthesis, this agent effectively targets a broad spectrum of susceptible organisms. This category provides essential reference standards, including the active pharmaceutical ingredient, diverse process-related and degradation-related impurities, diastereomeric mixtures, and sodium salts. These compounds are critical for pharmaceutical laboratories to perform rigorous impurity profiling, method validation, and routine quality control testing. Furthermore, stable isotope labelled versions of the drug and its related compounds are available to support advanced analytical requirements, such as precise quantification in pharmacokinetic studies and mass spectrometry-based assays. Utilizing these reference materials ensures consistency and compliance with regulatory standards for identity, purity, and safety throughout the pharmaceutical development and manufacturing lifecycle.